These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 19336039)

  • 1. Cold destabilization and temperature jump of the murine prion protein mPrP(23-231).
    Matsumoto T; Nakagawa T; Kuwata K
    Biochim Biophys Acta; 2009 Apr; 1794(4):669-73. PubMed ID: 19336039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative folding of murine prion mPrP(23-231).
    Lu BY; Beck PJ; Chang JY
    Eur J Biochem; 2001 Jul; 268(13):3767-73. PubMed ID: 11432744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extremely rapid folding of the C-terminal domain of the prion protein without kinetic intermediates.
    Wildegger G; Liemann S; Glockshuber R
    Nat Struct Biol; 1999 Jun; 6(6):550-3. PubMed ID: 10360358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folding intermediates of the prion protein stabilized by hydrostatic pressure and low temperature.
    Martins SM; Chapeaurouge A; Ferreira ST
    J Biol Chem; 2003 Dec; 278(50):50449-55. PubMed ID: 14525996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid folding of the prion protein captured by pressure-jump.
    Jenkins DC; Pearson DS; Harvey A; Sylvester ID; Geeves MA; Pinheiro TJT
    Eur Biophys J; 2009 Jun; 38(5):625-635. PubMed ID: 19255752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid core formed of full-length recombinant mouse prion protein involves sequence 127-143 but not sequence 107-126.
    Chatterjee B; Lee CY; Lin C; Chen EH; Huang CL; Yang CC; Chen RP
    PLoS One; 2013; 8(7):e67967. PubMed ID: 23844138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 3-disulfide mutant of mouse prion protein expression, oxidative folding, reductive unfolding, conformational stability, aggregation and isomerization.
    Lu BY; Chang JY
    Arch Biochem Biophys; 2007 Apr; 460(1):75-84. PubMed ID: 17320038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic intermediate in the folding of human prion protein.
    Apetri AC; Surewicz WK
    J Biol Chem; 2002 Nov; 277(47):44589-92. PubMed ID: 12356762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible aggregation of mouse prion protein derivatives with PrPSC-like structural properties.
    Lu BY; Atanasov I; Zhou ZH; Chang JY
    J Protein Chem; 2003 Feb; 22(2):115-26. PubMed ID: 12760416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The peculiar nature of unfolding of the human prion protein.
    Baskakov IV; Legname G; Gryczynski Z; Prusiner SB
    Protein Sci; 2004 Mar; 13(3):586-95. PubMed ID: 14767078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autonomous and reversible folding of a soluble amino-terminally truncated segment of the mouse prion protein.
    Hornemann S; Glockshuber R
    J Mol Biol; 1996 Sep; 261(5):614-9. PubMed ID: 8800210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability and conformational properties of doppel, a prion-like protein, and its single-disulphide mutant.
    Whyte SM; Sylvester ID; Martin SR; Gill AC; Wopfner F; Schätzl HM; Dodson GG; Bayley PM
    Biochem J; 2003 Jul; 373(Pt 2):485-94. PubMed ID: 12665426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogen/deuterium exchange mass spectrometry identifies two highly protected regions in recombinant full-length prion protein amyloid fibrils.
    Nazabal A; Hornemann S; Aguzzi A; Zenobi R
    J Mass Spectrom; 2009 Jun; 44(6):965-77. PubMed ID: 19283723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osmolyte trimethylamine N-oxide converts recombinant alpha-helical prion protein to its soluble beta-structured form at high temperature.
    Nandi PK; Bera A; Sizaret PY
    J Mol Biol; 2006 Sep; 362(4):810-20. PubMed ID: 16949096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of a polymerized prion protein.
    Lu BY; Chang JY
    Biochem J; 2002 May; 364(Pt 1):81-7. PubMed ID: 11988079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of isoforms of mouse prion protein with PrP(SC)-like structural properties.
    Lu BY; Chang JY
    Biochemistry; 2001 Nov; 40(44):13390-6. PubMed ID: 11683649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low entropic barrier to the hydrophobic collapse of the prion protein: effects of intermediate states and conformational flexibility.
    Bergasa-Caceres F; Rabitz HA
    J Phys Chem A; 2010 Jul; 114(26):6978-82. PubMed ID: 20540513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production, purification and oxidative folding of the mouse recombinant prion protein.
    Pavlícek A; Bednárová L; Holada K
    Folia Microbiol (Praha); 2007; 52(4):391-7. PubMed ID: 18062188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical region for amyloid fibril formation of mouse prion protein: unusual amyloidogenic properties of the helix 2 peptide.
    Yamaguchi K; Matsumoto T; Kuwata K
    Biochemistry; 2008 Dec; 47(50):13242-51. PubMed ID: 19053276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prion protein mPrP[F175A](121-231): structure and stability in solution.
    Christen B; Hornemann S; Damberger FF; Wüthrich K
    J Mol Biol; 2012 Nov; 423(4):496-502. PubMed ID: 22922482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.